Active-ingredient Dossier
Ziprasidone Hydrochloride
Active-ingredient Dossier for Ziprasidone Hydrochloride (atypical antipsychotic). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: ZIPROX
- Brand: APO-ZIPRASIDONE
- Brand: ZIPRASIDONE GH
- Brand: ZELDRAS
- Brand: ZIPRASIDONE
- Brand: ZIPRASIDONE-WGR
- Therapeutic area: Psychiatry
- Therapeutic area: Neurology
What is
Ziprasidone Hydrochloride Ziprasidone Hydrochloride is an atypical antipsychotic.
Australian brands containing
Ziprasidone Hydrochloride — ZIPROX — APO-ZIPRASIDONE — ZIPRASIDONE GH — ZELDRAS — ZIPRASIDONE — ZIPRASIDONE-WGR
Therapeutic areas
Ziprasidone Hydrochloride is registered in Neurology, with 6 brands containing the ingredient on the ARTG.
Sponsor landscape
Three sponsors market Ziprasidone Hydrochloride in Australia: Arrotex Pharmaceuticals, GM Pharma, and Generic Health.
PBS and regulatory activity
One brand containing Ziprasidone Hydrochloride has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome for the ingredient is dated 1 November 2008, and no AusPARs have been recorded for Ziprasidone Hydrochloride.